Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune system. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designe... Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune system. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -2.3523 | -19.538673666 | 12.0392 | 12.39 | 9.6 | 206386 | 11.18477151 | CS |
| 4 | -2.8131 | -22.5048 | 12.5 | 13.28 | 9.6 | 200416 | 12.05615978 | CS |
| 12 | -7.7531 | -44.4558486239 | 17.44 | 20.77 | 9.6 | 283615 | 15.31188175 | CS |
| 26 | -49.1731 | -83.5424736663 | 58.86 | 61.9 | 9.6 | 468795 | 24.61176774 | CS |
| 52 | -15.2131 | -61.0967871486 | 24.9 | 61.9 | 9.6 | 416963 | 30.25065599 | CS |
| 156 | -4.4071 | -31.2693344686 | 14.094 | 61.9 | 2.11 | 1004384 | 10.65508365 | CS |
| 260 | -188.0131 | -95.1002023268 | 197.7 | 322.5 | 2.11 | 2163968 | 58.54775655 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
